Paper39927770
Recent developments in Aspergillus fumigatus research: diversity, drugs, and disease.
Kordana N and 4 others. Microbiol Mol Biol Rev, 2025. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Recent developments in Aspergillus fumigatus research: diversity, drugs, and disease. Papers, record 39927770. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39927770
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aspergillus fumigatus | Major topic |
| Aspergillosis | Major topic |
| Antifungal Agents | Major topic |
| Humans | |
| Drug Resistance, Fungal | |
| Animals | |
| Triazoles |
Source PubMed
Grants11
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI130128 | NIAID NIH HHS | United States | R01AI130128 | PubMed and NIH | NIH RePORTER |
| T32AI007519 | HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) | T32AI007519 | PubMed and NIH | NIH RePORTER | |
| T32 AI007519 | NIAID NIH HHS | United States | T32AI007519 | PubMed and NIH | NIH RePORTER |
| R01 AI139133 | NIAID NIH HHS | United States | R01AI139133 | PubMed and NIH | NIH RePORTER |
| T32HL134598 | HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) | T32HL134598 | PubMed and NIH | NIH RePORTER | |
| R01AI139133 | HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) | R01AI139133 | PubMed and NIH | NIH RePORTER | |
| T32 HL134598 | NHLBI NIH HHS | United States | T32HL134598 | PubMed and NIH | NIH RePORTER |
| 005808G223-Cramer | Cystic Fibrosis Foundation (CFF) | PubMed | PubMed | ||
| R01 AI146121 | NIAID NIH HHS | United States | R01AI146121 | PubMed and NIH | NIH RePORTER |
| R01 AI181215 | NIAID NIH HHS | United States | R01AI181215 | PubMed and NIH | NIH RePORTER |
| R01AI181215, R01AI130128 | HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) | R01AI181215 | PubMed and NIH | NIH RePORTER |
References384
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26667837 | Polymorphisms in Host Immunity-Modulating Genes and Risk of Invasive Aspergillosis: Results from the AspBIOmics Consortium. | Infect Immun | 2015 | https://conductscience.org/library/papers/26667837 | PubMed |
| 2 | 35680499 | Recombinant Aspergillus fumigatus antigens Asp f 3 and Asp f 9 in liposomal vaccine protect mice against invasive pulmonary aspergillosis. | Vaccine | 2022 | https://conductscience.org/library/papers/35680499 | PubMed |
| 3 | 33593969 | A Heterogeneously Expressed Gene Family Modulates the Biofilm Architecture and Hypoxic Growth of Aspergillus fumigatus. | mBio | 2021 | https://conductscience.org/library/papers/33593969 | PubMed |
| 4 | 38130371 | Isolated renal and urinary tract aspergillosis: a systematic review. | Ther Adv Urol | 2023 | https://conductscience.org/library/papers/38130371 | PubMed |
| 5 | 32291301 | Human Neutrophils Produce Antifungal Extracellular Vesicles against Aspergillus fumigatus. | mBio | 2020 | https://conductscience.org/library/papers/32291301 | PubMed |
| 6 | 35560045 | Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T-cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant. | Am J Hematol | 2023 | https://conductscience.org/library/papers/35560045 | PubMed |
| 7 | 35652640 | Horizontal Gene Transfer of Triazole Resistance in Aspergillus fumigatus. | Microbiol Spectr | 2022 | https://conductscience.org/library/papers/35652640 | PubMed |
| 8 | 38990800 | Unraveling the genomic diversity and virulence of human fungal pathogens through pangenomics. | PLoS Pathog | 2024 | https://conductscience.org/library/papers/38990800 | PubMed |
| 9 | 28423062 | Filamentous fungal carbon catabolite repression supports metabolic plasticity and stress responses essential for disease progression. | PLoS Pathog | 2017 | https://conductscience.org/library/papers/28423062 | PubMed |
| 10 | 32357408 | Evaluation of Droplet Digital Polymerase Chain Reaction (ddPCR) for the Absolute Quantification of Aspergillus species in the Human Airway. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32357408 | PubMed |
| 11 | 27048799 | Deacetylation of Fungal Exopolysaccharide Mediates Adhesion and Biofilm Formation. | mBio | 2016 | https://conductscience.org/library/papers/27048799 | PubMed |
| 12 | 33593906 | Dual-purpose isocyanides produced by Aspergillus fumigatus contribute to cellular copper sufficiency and exhibit antimicrobial activity. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/33593906 | PubMed |
| 13 | 34173659 | Prospective Evaluation of Galactomannan and (1→3) β-d-Glucan Assays as Diagnostic Tools for Invasive Fungal Disease in Children, Adolescents, and Young Adults With Acute Myeloid Leukemia Receiving Fungal Prophylaxis. | J Pediatric Infect Dis Soc | 2021 | https://conductscience.org/library/papers/34173659 | PubMed |
| 14 | 39189854 | Elexacaftor/Tezacaftor/Ivacaftor Markedly Reduces Aspergillus fumigatus in Cystic Fibrosis. | Am J Respir Crit Care Med | 2024 | https://conductscience.org/library/papers/39189854 | PubMed |
| 15 | 34790195 | Nlrx1-Regulated Defense and Metabolic Responses to Aspergillus fumigatus Are Morphotype and Cell Type Specific. | Front Immunol | 2021 | https://conductscience.org/library/papers/34790195 | PubMed |
| 16 | 38403258 | Time-resolved fluoroimmunoassay for Aspergillus detection based on anti-galactomannan monoclonal antibody from stable cell line. | Anal Biochem | 2024 | https://conductscience.org/library/papers/38403258 | PubMed |
| 17 | 22108383 | Identification and characterization of an Aspergillus fumigatus "supermater" pair. | mBio | 2011 | https://conductscience.org/library/papers/22108383 | PubMed |
| 18 | 25537876 | Common severe infections in chronic granulomatous disease. | Clin Infect Dis | 2015 | https://conductscience.org/library/papers/25537876 | PubMed |
| 19 | 28947643 | Interleukin 1α Is Critical for Resistance against Highly Virulent Aspergillus fumigatus Isolates. | Infect Immun | 2017 | https://conductscience.org/library/papers/28947643 | PubMed |
| 20 | 32956405 | NLRX1 is a key regulator of immune signaling during invasive pulmonary aspergillosis. | PLoS Pathog | 2020 | https://conductscience.org/library/papers/32956405 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42655757 | The Janus Face of Aspergillus in Fish Aquaculture: From Pathogenic Threat to Functional Feed Additive. | Vet Sci | 2026 | https://conductscience.org/library/papers/42655757 | PubMed |
| 42655049 | Antifungal Susceptibility and Cyp51A Gene Variation Analysis of Aspergillus fumigatus Isolated from Soils in Tea-Growing Areas of Guizhou, China. | Microorganisms | 2026 | https://conductscience.org/library/papers/42655049 | PubMed |
| 42615624 | Identification and characterization of non-canonical azole antifungal resistance pathways in Aspergillus fumigatus. | mBio | 2026 | https://conductscience.org/library/papers/42615624 | PubMed |
| 42447002 | The power of ten: report from the 10th American Society for Microbiology Conference on Biofilms. | J Bacteriol | 2026 | https://conductscience.org/library/papers/42447002 | PubMed |
| 42132439 | A ceramide synthase is important for filamentous fungal biofilm morphology and antifungal drug susceptibility. | mBio | 2026 | https://conductscience.org/library/papers/42132439 | PubMed |
| 42084394 | Multi-omics profiling of fungal balls in chronic pulmonary aspergillosis patients reveals microbiome dynamics and metabolic adaptations. | mBio | 2026 | https://conductscience.org/library/papers/42084394 | PubMed |
| 42060100 | Investigation of chitinase B1 inhibitors targeting the cell wall biosynthetic machinery in Aspergillus fumigatus through integrated molecular dynamics and QM/MM. | Folia Microbiol (Praha) | 2026 | https://conductscience.org/library/papers/42060100 | PubMed |
| 41968318 | RTA-like proteins regulate azole susceptibility by affecting the expression of the oxidoreductase gene oxrA in Aspergillus fumigatus. | BMC Microbiol | 2026 | https://conductscience.org/library/papers/41968318 | PubMed |
| 41968250 | Electrophoretic Mobility Shift Assay in Aspergillus fumigatus. | Methods Mol Biol | 2026 | https://conductscience.org/library/papers/41968250 | PubMed |
| 41948395 | Nebulized Liposomal Amphotericin B as an Alternative Therapy for an Aspergillus Tracheal Plaque. | Case Rep Infect Dis | 2026 | https://conductscience.org/library/papers/41948395 | PubMed |
| 41928566 | HosA-mediated epigenetic regulation of growth, virulence, and secondary metabolism in Aspergillus fumigatus. | Virulence | 2026 | https://conductscience.org/library/papers/41928566 | PubMed |
| 41871161 | Functional and molecular characterization of Aspergillus fumigatus phosphoglucomutase (Pgm): a potential target for antifungal therapy. | J Med Microbiol | 2026 | https://conductscience.org/library/papers/41871161 | PubMed |
| 41860106 | High-Volume Culture Improves Diagnostic Yield of Aspergillus Species From Sputum. | Mycoses | 2026 | https://conductscience.org/library/papers/41860106 | PubMed |
| 41597755 | Novel Genetic Diversity and Geographic Structures of Aspergillus fumigatus (Order Eurotiales, Family Aspergillaceae) in the Karst Regions of Guizhou, China. | Microorganisms | 2026 | https://conductscience.org/library/papers/41597755 | PubMed |
| 41436940 | Geographically structured genotypes and resistance clustering in Aspergillus fumigatus. | Eur J Clin Microbiol Infect Dis | 2026 | https://conductscience.org/library/papers/41436940 | PubMed |
| 41343262 | Emergence, function, and therapeutic strategies to target the PD-1/PD-L1 immune checkpoint during pathogenic fungal infections. | Virulence | 2025 | https://conductscience.org/library/papers/41343262 | PubMed |
| 40232283 | Human immunity to fungal infections. | J Exp Med | 2025 | https://conductscience.org/library/papers/40232283 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39927770
GET https://conductscience.org/api/papers/v1/39927770/references?page=2